|
|
||||||||||
|
J Am Coll Cardiol, 2006; 47:594-597, doi:10.1016/j.jacc.2005.09.044
(Published online 13 January 2006). © 2006 by the American College of Cardiology Foundation |
Department of Cardiology, Hôpital de la Cavale Blanche, Brest University Hospital, Brest, France
Manuscript received July 8, 2005; revised manuscript received August 31, 2005, accepted September 8, 2005.
* Reprint requests and correspondence: Dr. Jean-Jacques Blanc, Department of Cardiology, Brest University Hospital, Boulevard Tanguy Prigent, 29609 Brest Cedex, France (Email: jean-jacques.blanc{at}univ-brest.fr).
OBJECTIVES: We sought to evaluate epidemiology, clinical features, and outcomes of patients with syncope and an abnormal response to adenosine triphosphate (ATP).
BACKGROUND: Syncope remains of unknown origin in almost 30% of the patients. Injection of ATP induces in some of these patients, but not in control patients, a ventricular pause
6 s.
METHODS: Patients with syncope of unknown origin had an intravenous injection of 20 mg of ATP. All patients had a tilt test.
RESULTS: Among 214 patients, 19 (8.9%) had a positive ATP test result. The proportion of positive test results was higher (p < 0.002) in women (14.3%) than in men (2.2%). Ten patients (4.7%) had positive ATP and tilt test results. These patients (exclusively women) were older (p < 0.05) at the time of their fist syncope than the 67 patients with a negative ATP test result but a positive tilt test result. There was a trend for these two test results to be correlated (p = 0.07). Side effects were of short duration and benign. The mean duration of pauses was longer in women (p = 0.009). During a mean period of 31 ± 14 months, recurrences of syncope were reported in 25% of patients.
CONCLUSIONS: The ATP test is a safe test with an "abnormal" result in <10% of patients with syncope of unknown origin. The profile of these patients is characteristic.
| |||||||
This article has been cited by other articles:
![]() |
S. Viskin, D. Justo, and A. Halkin Should the 'adenosine-challenge test' be part of the routine work-up for syncope? Europace, August 1, 2007; 9(8): 557 - 558. [Full Text] [PDF] |
||||
![]() |
M. Brignole, R. Sutton, C. Menozzi, R. Garcia-Civera, A. Moya, W. Wieling, D. Andresen, D. G. Benditt, N. Grovale, T. De Santo, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope Eur. Heart J., September 2, 2006; 27(18): 2232 - 2239. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |